Global Food Grade Nicotinamide Mononucleotide Hydride (NMNH) Market Growth 2025-2031

The global Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market size is predicted to grow from US$ 67.4 million in 2025 to US$ 105 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

Food Grade Nicotinamide Mononucleotide Hydride (NMNH) is an ingredient used in foods and dietary supplements. NMNH, also known as reduced nicotinamide mononucleotide or reduced β-NMN, is the reduced form of β-NMN, an important precursor for the biosynthesis of NAD+ (nicotinamide adenine dinucleotide). NAD+ is an important coenzyme in the human body that supports a variety of cellular functions, including energy production, DNA repair, and overall metabolic health. NMNH has attracted attention for its potential to promote healthy aging and enhance metabolic function.

United States market for Food Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Food Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Food Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Food Grade Nicotinamide Mononucleotide Hydride (NMNH) players cover Hygieia Biotech, ChromaDex Corp., EffePharm, Bontac Bio-Engineering (Shenzhen) Co., Ltd., Bicells Science Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Food Grade Nicotinamide Mononucleotide Hydride (NMNH) Industry Forecast” looks at past sales and reviews total world Food Grade Nicotinamide Mononucleotide Hydride (NMNH) sales in 2024, providing a comprehensive analysis by region and market sector of projected Food Grade Nicotinamide Mononucleotide Hydride (NMNH) sales for 2025 through 2031. With Food Grade Nicotinamide Mononucleotide Hydride (NMNH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Food Grade Nicotinamide Mononucleotide Hydride (NMNH) industry.

This Insight Report provides a comprehensive analysis of the global Food Grade Nicotinamide Mononucleotide Hydride (NMNH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Food Grade Nicotinamide Mononucleotide Hydride (NMNH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Food Grade Nicotinamide Mononucleotide Hydride (NMNH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Food Grade Nicotinamide Mononucleotide Hydride (NMNH).

This report presents a comprehensive overview, market shares, and growth opportunities of Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
>95%
>99%
＞99.5%

Segmentation by Application:
Food Additives
Health Products

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hygieia Biotech
ChromaDex Corp.
EffePharm
Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Bicells Science Ltd.
Xi'an Green Biotechnique Co.,Ltd.
InnovaSyn Biotech Inc.
Bonerge Lifescience
Xi’an Core Pure Co., Ltd
Provita Biotech Co., Ltd.
SENTIANBIO
Xi'an Haoze Biotechnology Co., Ltd.
Maintain Biotech Co.,Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market?

What factors are driving Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Food Grade Nicotinamide Mononucleotide Hydride (NMNH) market opportunities vary by end market size?

How does Food Grade Nicotinamide Mononucleotide Hydride (NMNH) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.